BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 240 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 1.6%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $266,638,000 | +4.9% | 1,763,828 | +1.1% | 0.02% | +13.3% |
| Q2 2022 | $254,271,000 | +29.5% | 1,745,046 | +5.4% | 0.02% | +50.0% |
| Q1 2022 | $196,332,000 | -13.5% | 1,655,834 | +0.5% | 0.01% | -9.1% |
| Q4 2021 | $227,069,000 | +10.1% | 1,647,694 | +11.0% | 0.01% | 0.0% |
| Q3 2021 | $206,272,000 | +43.5% | 1,484,930 | +0.3% | 0.01% | +37.5% |
| Q2 2021 | $143,733,000 | +37.0% | 1,480,567 | -3.5% | 0.01% | +33.3% |
| Q1 2021 | $104,900,000 | -26.8% | 1,534,744 | -8.2% | 0.01% | -33.3% |
| Q4 2020 | $143,303,000 | +24.3% | 1,671,949 | -5.7% | 0.01% | +12.5% |
| Q3 2020 | $115,274,000 | -11.0% | 1,773,172 | +0.1% | 0.01% | -11.1% |
| Q2 2020 | $129,457,000 | +92.5% | 1,770,709 | -10.4% | 0.01% | +50.0% |
| Q1 2020 | $67,241,000 | -35.4% | 1,975,941 | +3.4% | 0.01% | -14.3% |
| Q4 2019 | $104,057,000 | +22.0% | 1,911,408 | -6.5% | 0.01% | +16.7% |
| Q3 2019 | $85,315,000 | +22.7% | 2,044,943 | +28.8% | 0.01% | +20.0% |
| Q2 2019 | $69,537,000 | +0.9% | 1,587,957 | +18.6% | 0.01% | 0.0% |
| Q1 2019 | $68,921,000 | +84.3% | 1,339,048 | +32.4% | 0.01% | +66.7% |
| Q4 2018 | $37,406,000 | -24.7% | 1,011,514 | -23.5% | 0.00% | -25.0% |
| Q3 2018 | $49,655,000 | -15.7% | 1,322,355 | -11.3% | 0.00% | -20.0% |
| Q2 2018 | $58,928,000 | +349.6% | 1,490,952 | +193.0% | 0.01% | +400.0% |
| Q1 2018 | $13,106,000 | +171.7% | 508,803 | +184.5% | 0.00% | – |
| Q4 2017 | $4,823,000 | -19.7% | 178,817 | +11.2% | 0.00% | -100.0% |
| Q3 2017 | $6,009,000 | +104.8% | 160,775 | +37.2% | 0.00% | – |
| Q2 2017 | $2,934,000 | – | 117,212 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |